154.54
price down icon3.16%   -5.04
pre-market  Vorhandelsmarkt:  154.24   -0.30   -0.19%
loading

Finanzdaten der Charles River Laboratories International Inc-Aktie (CRL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-28 2025-03-29 2024-12-28 2024-09-28 2024-06-29
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.87%
1,032.13
984.17 1,002.55 1,009.76 1,026.12
Operating Expenses
2.47%
932.00
909.50 3,170.10 231.62 202.06
Benefits Costs and Expenses
-
- 3,956.88 - -
Costs And Expenses
2.47%
932.00
909.50 1,304.47 892.36 874.47
Operating Income/Loss
34.10%
100.13
74.67 -167.69 117.41 151.65
Income/Loss From Continuing Operations Before Tax
4.87%
1,032.13
984.17 -2,954.33 1,009.76 1,026.12
Income Tax Expense/Benefit
85.40%
18.73
10.10 -3.044 20.95 25.39
Income/Loss From Continuing Operations After Tax
103.62%
52.69
25.88 -213.75 70.30 94.26
Net Income/Loss
103.62%
52.69
25.88 -213.75 70.30 94.26
Preferred Stock Dividends And Other Adjustments
-
- 1.204 0.978 4.093
Attributable To Noncontrolling Interest
10.27%
0.367
0.409 0.748 0.638 0.18
Basic Average Shares
3.02%
49.15
50.68 -0.081 51.39 51.55
Diluted Average Shares
3.02%
49.32
50.85 -0.085 51.58 51.85
Basic Earnings Per Share
112.00%
1.06
0.50 -4.19 1.34 1.75
Diluted Earnings Per Share
112.00%
1.06
0.50 -4.17 1.33 1.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 1.204 0.978 4.093
diagnostics_research WAT
$290.44
price down icon 2.12%
diagnostics_research DGX
$183.72
price down icon 0.37%
$161.95
price up icon 0.82%
diagnostics_research LH
$276.56
price down icon 0.55%
diagnostics_research MTD
$1,278.00
price down icon 2.95%
diagnostics_research IQV
$185.39
price down icon 3.46%
Kapitalisierung:     |  Volumen (24h):